- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
ATRX immunostaining predicts IDH and H3F3A status in gliomas ; volume:4 ; number:1 ; day:16 ; month:6 ; year:2016 ; pages:1-10 ; date:12.2016
Acta Neuropathologica Communications ; 4, Heft 1 (16.6.2016), 1-10, 12.2016
- Urheber
- Beteiligte Personen und Organisationen
-
Skardelly, Marco
Bonzheim, Irina
Ott, Ines
Mühleisen, Helmut
Eckert, Franziska
Tabatabai, Ghazaleh
Schittenhelm, Jens
SpringerLink (Online service)
- DOI
-
10.1186/s40478-016-0331-6
- URN
-
urn:nbn:de:1111-2016061722819
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ebrahimi, Azadeh
- Skardelly, Marco
- Bonzheim, Irina
- Ott, Ines
- Mühleisen, Helmut
- Eckert, Franziska
- Tabatabai, Ghazaleh
- Schittenhelm, Jens
- SpringerLink (Online service)
Ähnliche Objekte (12)
Therapies for IDH-Mutant Gliomas
Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET
Stalled oligodendrocyte differentiation in IDH-mutant gliomas
Methylation class oligosarcoma may encompass IDH-wildtype gliomas
Seizures in patients with IDH-mutated lower grade gliomas
Characteristics of gliomas in patients with somatic IDH mosaicism
Proteomic Exploration of IDH-Mutant Gliomas using Mass Spectrometry
Predicting IDH genotype in gliomas using FET PET radiomics
Longitudinal DNA methylation analysis of adult-type IDH-mutant gliomas
Determinants of long-term survival in patients with IDH-mutant gliomas
Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas
Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas
Therapies for IDH-Mutant Gliomas
Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET
Stalled oligodendrocyte differentiation in IDH-mutant gliomas
Methylation class oligosarcoma may encompass IDH-wildtype gliomas
Seizures in patients with IDH-mutated lower grade gliomas
Characteristics of gliomas in patients with somatic IDH mosaicism
Proteomic Exploration of IDH-Mutant Gliomas using Mass Spectrometry
Predicting IDH genotype in gliomas using FET PET radiomics
Longitudinal DNA methylation analysis of adult-type IDH-mutant gliomas
Determinants of long-term survival in patients with IDH-mutant gliomas
Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas
Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas
Therapies for IDH-Mutant Gliomas
Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET
Stalled oligodendrocyte differentiation in IDH-mutant gliomas
Methylation class oligosarcoma may encompass IDH-wildtype gliomas
Seizures in patients with IDH-mutated lower grade gliomas
Characteristics of gliomas in patients with somatic IDH mosaicism
Proteomic Exploration of IDH-Mutant Gliomas using Mass Spectrometry
Predicting IDH genotype in gliomas using FET PET radiomics
Longitudinal DNA methylation analysis of adult-type IDH-mutant gliomas
Determinants of long-term survival in patients with IDH-mutant gliomas
Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas